Business Context and Reporting Period
This Form 8-K Current Report, dated June 6, 2025, covers the 2025 Annual Meeting of Stockholders for Omega Healthcare Investors, Inc. (OHI). The filing details the outcomes of shareholder votes, amendments to the company's charter, and changes to the Board of Directors' committee memberships.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. No financial statements are included in this document.
Material Changes and Corporate Actions
- Charter Amendment Approved: Stockholders approved an amendment to increase the number of authorized common shares from 350,000,000 to 700,000,000 shares.
- Shareholder Participation: Approximately 84.29% of total outstanding common stock (242,057,737 shares) was present or represented by proxy at the meeting.
- Board Committee Restructuring: Effective immediately following the meeting, Stephen D. Plavin was appointed to the Investment Committee, replacing C. Taylor Pickett. Mr. Plavin ceased serving on the Compensation Committee.
Voting Results and Management Commentary
All four proposals submitted to the stockholders were approved. The specific voting results were as follows:
- Proposal 1 (Election of Directors): All eight nominees were elected. Votes ranged from approximately 188 million to 196 million "For" votes.
- Proposal 2 (Ratification of Auditors): Ernst & Young LLP was ratified as the independent auditor for Fiscal Year 2025 with 230,705,879 "For" votes.
- Proposal 3 (Advisory Vote on Executive Compensation): Approved with 190,077,014 "For" votes.
- Proposal 4 (Charter Amendment): Approved with 231,662,341 "For" votes.
Updated Committee Membership:
- Audit Committee: Kapila K. Anand (Chair), Craig R. Callen, Kevin J. Jacobs, Burke W. Whitman.
- Compensation Committee: Burke W. Whitman (Chair), Barbara B. Hill, Dr. Lisa C. Egbuonu-Davis.
- Investment Committee: Craig R. Callen (Chair), Kapila K. Anand, Kevin J. Jacobs, Stephen D. Plavin.
- Nominating and Corporate Governance Committee: Stephen D. Plavin (Chair), Craig R. Callen, Dr. Lisa C. Egbuonu-Davis, Barbara B. Hill.
Investor Verification Checklist
- Verify the updated authorized share count of 700,000,000 in the company's Articles of Amendment and Restatement (Exhibit 3.1).
- Confirm the new composition of the Investment and Compensation Committees for future governance analysis.
- Review the definitive proxy statement filed on April 22, 2025, for the full text of the charter amendment.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial performance metrics.